Blaisdell, F.W. : Pathophysiology of the respiratory distress syndrome. Arch. Surg., 108: 44, 1974.
3.
Berman, I.R. : Intravascular microaggregation and the respiratory distress syndrome. Pediatr. Clin. North Am., 22: 275, 1975.
4.
Rådegran, K. : Circulatory and respiratory effects of induced platelets aggregation. An experimental study in dogs. Acta Chir. Scand., 420 (Suppl.): 1, 1971.
5.
Bo, G., Hognestad, J.: Effects on the pulmonary circulation of suddenly induced intravascular aggregation of blood platelets. Acta Physiol. Scand., 85: 523, 1972.
6.
Vaage, J., Bo, G., Hognestad, J.: Pulmonary responses to intravascular platelet aggregation in the cat . Acta Physiol. Scand., 92: 546, 1974.
7.
Reeves, J.T. , Jokl, P., Merida , J., et al.: Pulmonary vascular obstruction following administration of high-energy nucleotides. J. Appl. Physiol. , 22: 475, 1967.
8.
Hissen, W., Swank, R.L.: Screen filtration pressure and pulmonary hypertension. Am. J. Physiol., 209: 715, 1965.
9.
Robb, H.J., Margulis, R.R., Jabs, C.M.: Role of pulmonary microembolism in the hemodynamics of endotoxin shock . Surg. Gynecol. Obstet., 135: 777, 1972.
10.
Stein, M., Thomas, D.P.: Role of platelets in the acute pulmonary response to endotoxin. J. Appl. Physiol., 23: 47, 1967.
11.
Swedenborg, J.: On the role of vasoactive substances in haemodynamic changes induced by thrombin. Acta Chir. Scand., 413 (Suppl.): 7, 1971.
12.
Hyman, A.L. , Woolverton, W.C., Penning-ton , D.G., et al.: Pulmonary vascular responses to adenosine diphosphate. J. Pharmacol. Exp. Ther., 178: 549, 1971.
13.
Hughes, A., Tonks, R.S.: Intravascular platelet clumping in rabbits. J. Pathol. Bactiol.,84: 379, 1962.
14.
Jørgensen, L., Rowsell, H.C., Hovig , T., et al.: Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine . Lab. Invest. , 17: 616, 1967.
15.
Jørgensen, L., Hovig, T., Rowsell , H.C., et al.: Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits. Am. J. Pathol., 61: 161, 1970.
16.
Furlow, T.W. , Bass, N.H.: Stroke in rats produced by carotid injection of sodium arachidonate. Science, 187: 658, 1975 .
17.
Svensson, J. , Hamberg, M., Samuelsson, B.: Prostaglandin endoperoxides. IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets. Acta Physiol. Scand., 94: 222, 1975.
18.
Smith, P., Heath, D.: Ultrastructure of hypoxic hypertensive pulmonary vascular disease . J. Pathol., 121: 93, 1977.
19.
Smith, P., Heath, D.: Evagination of vascular smooth muscle cells during the early stages of Crotalaria pulmonary hypertension. J. Pathol., 124: 177, 1978 .
20.
Willis, A.L. : An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin. Science, 183: 325, 1974.
21.
Dexter, L.: Cardiovascular responses to experimental pulmonary embolism, in Pulmonary Embolic Disease. Edited by A.A. Sasahara, M. Stein.New York, Grune & Stratton, 1965, pp. 101-109.
22.
MacIntyre, D.E. : The platelet release reaction: Association with adhesion and aggregation, and comparison with secretory responses in other cells, in Platelets in Biology and Pathology. Edited by J.L.Gordon. Amsterdam, Elsevier/North-Holland, 1976, pp. 61-85.
23.
Rose, J.C., Lazaro, E.J.: Pulmonary vascular responses to serotonin and effects of certain serotonin antagonists. Circ. Res., 6: 282, 1958.
24.
Rudolph, A.M. , Kurland, M.H., Auld , P.A.M., et al.: Effects of vasodilator drugs on normal and serotonin-constricted pulmonary vessels of the dog. Am. J. Physiol., 197: 617, 1959 .
25.
Hamberg, M. , Samuelsson, B.: Novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. U.S.A.,71: 3400, 1974.
26.
Smith, J.B. , Ingerman, C., Kocsis , J.J., et al.: Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction . J. Clin. Invest., 53: 1468, 1974.
27.
Willis, A.L. , Vane, F.M., Kuhn , D.C., et al.: An endoperoxide aggregator (LASS) formed in platelets in response to thrombotic stimuli. Prostaglandins , 8: 453, 1974.
28.
Malmsten, C. , Hamberg, M., Svensson , J., et al.: Physiological role of an endoperoxide in human platelet: Hemostatic defect due to platelet cyclo-oxygenase deficiency . Proc. Natl. Acad. Sci. U.S.A. , 72: 1446, 1972 .
29.
Hamberg, M. , Svensson, J., Samuelsson , B.: Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides . Proc. Natl. Acad. Sci. U.S.A., 72: 2994, 1975 .
30.
Hamberg, M. , Svensson, J., Wakabayashi , T., et al.: Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation . Proc. Natl. Acad. Sci. U.S.A., 71: 345, 1974.
31.
Ellis, E.F. , Oelz, O., Roberts , J., et al.: Coronary artery smooth muscle contraction by a substance released from platelets: Evidence that it is thromboxane A 2. Science,193: 1135, 1976.
32.
Svensson, J. , Hamberg, M.: Thromboxane A2 and prostaglandin H2: Potent stimulators of the swine coronary artery . Prostaglandins,12: 943, 1976.
Mustard, J.F. , Movat, H.Z., Macmorine , R.L., et al.: Release of permeability factors from the blood platelet. Proc. Exp. Biol. Med., 119: 988, 1965.
35.
Majino, G., Palade, G.E.: Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: An electron microscopic study. J. Biophys. Biochem. Cytol., 11: 571, 1961.
36.
Henson, P.M. , Cochrane, C.G.: Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving compliment. J. Exp. Med., 129: 167, 1969 .
37.
Nachman, R.L. , Weksler, B., Ferris , B.: Increased vascular permeability produced by human platelet granule cationic extract. J. Clin. Invest. , 49: 274, 1970.